Search - Université de Rennes Access content directly

Filter your results

10 Results
authFullName_s : Ronald Levy
Image document

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

June H. Myklebust , Joshua Brody , Holbrook E. Kohrt , Arne Kolstad , Debra K. Czerwinski et al.
Blood, 2017, 129 (6), pp.759-770. ⟨10.1182/blood-2016-05-718494⟩
Journal articles hal-01475956v1

Immunomodulating antibodies and drugs for the treatment of hematological malignancies.

Roch Houot , Holbrook Kohrt , Matthew J. Goldstein , Ronald Levy
Cancer and Metastasis Reviews, 2011, 30 (1), pp.97-109. ⟨10.1007/s10555-011-9274-3⟩
Journal articles istex hal-00744073v1

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.

Holbrook E. Kohrt , Roch Houot , Matthew J. Goldstein , Kipp Weiskopf , Ash A. Alizadeh et al.
Blood, 2011, 117 (8), pp.2423-32. ⟨10.1182/blood-2010-08-301945⟩
Journal articles hal-00743985v1

Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy.

Roch Houot , Holbrook E. Kohrt , Aurélien Marabelle , Ronald Levy
Trends in Immunology, 2011, 32 (11), pp.510-6. ⟨10.1016/j.it.2011.07.003⟩
Journal articles istex hal-00744044v1
Image document

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.

Holbrook E. Kohrt , Roch Houot , Kipp Weiskopf , Matthew J. Goldstein , Ferenc Scheeren et al.
Journal of Clinical Investigation, 2012, 122 (3), pp.1066-75. ⟨10.1172/JCI61226⟩
Journal articles inserm-00869052v1

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.

Ash A. Alizadeh , Andrew J. Gentles , Alvaro J. Alencar , Chih Long Liu , Holbrook E. Kohrt et al.
Blood, 2011, 118 (5), pp.1350-8. ⟨10.1182/blood-2011-03-345272⟩
Journal articles hal-00743991v1

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas

Ajay K Gopal , Ronald Levy , Roch Houot , Sandip P Patel , Leslie Popplewell et al.
Clinical Cancer Research, 2020, 26 (11), pp.2524-2534. ⟨10.1158/1078-0432.CCR-19-2973⟩
Journal articles hal-02563360v1
Image document

Targeting CD137 enhances the efficacy of cetuximab.

Holbrook E Kohrt , a Dimitrios Colevas , Roch Houot , Kipp Weiskopf , Matthew J Goldstein et al.
Journal of Clinical Investigation, 2014, 124 (6), pp.2668-82. ⟨10.1172/JCI73014⟩
Journal articles hal-01021651v1
Image document

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Roch Houot , Ronald Levy , Guillaume Cartron , Philippe Armand
European Journal of Cancer, 2020, 136, pp.4-6. ⟨10.1016/j.ejca.2020.06.017⟩
Journal articles hal-02929021v1
Image document

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma

John Timmerman , Charles Herbaux , Vincent Ribrag , Andrew D. Zelenetz , Roch Houot et al.
American Journal of Hematology, 2020, 95 (5), pp.510-520. ⟨10.1002/ajh.25757⟩
Journal articles hal-02798009v1